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Summary The activities and the expression of 3-methyladenine glycosylase (3-meAde gly) and O6-
alkylguanine-DNA-alkyltransferase (06ATase) were investigated in ten human cancer cell lines. Both 3-meAde
gly and 06ATase activities were variable among different cell lines. mRNA levels of the 06ATase gene,
appeared to be related to the content of 06ATase in different cell lines, whereas no apparent correlation was
found between mRNA of 3-meAde gly and the enzymatic activity. No correlation was found between the
activity of the two enzymes and the sensitivity to alkylating agents of different structures such as CC-1065,
tallimustine, dimethylsulphate (DMSO), N-methyl-N'-nitro-N-ntirosoguanidine (MNNG), cis-diamminedi-
chloroplatinum (cDDP) and melphalan (L-PAM). The most striking finding of this study is that a correlation
exists between the activity of O6ATase and 3-meAde gly in the various cell lines investigated (P<0.01),
suggesting a common mechanism of regulation of two DNA repair enzymes.
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Alkylating agents can cause a variety of DNA adducts, the
alkylpurines being the main ones (Baranek, 1990; Margison
and O'Connor, 1990). These alkylations are eliminated in
prokaryotes and eukaryotes (Olsson and Lindahl, 1980;
Mehta et al., 1981; Lindahl, 1976; Laval, 1977) through an
o6 alkylguanine alkyltransferase (O6ATase) acting on o6
methylguanine (06-meGua) and a 3-methyladenine glycosy-
lase (3-meAde gly) acting on a 3-methyladenine (3-meAde)
and other alkylpurines.
The molecular effect of alkylation of guanines at the o6
position is well defined, resulting in a mismatch and, after
DNA replication, in a transition mutation (Loveless, 1969).
Such DNA lesions can cause lethal events through an
abortive mismatch repair (Kat et al., 1993). In this respect
the role of O6ATase has been related to resistance to
alkylating agents in various biological systems, from
prokaryotes to mammals. Less is known about the 3-
alkyladenine in DNA. While in Escherichia coli such
alkylated bases represent a lethal event (Boiteux et al.,
1984; Lindahl et al., 1988), it is still to be confirmed whether
it is lethal or mutagenic in mammalian cells. E. coli displays
two glycosylase activities able to repair 3-alkyladenine,
encoded by the tag and alkA gene products (Bjelland et al.,
1993; Nakabeppu et al., 1994).
Mammalian cells seem to have only one type of adenine
glycosylase, more like the alkA than the tag gene product.
Recently the mouse, rat and human 3-meAde gly cDNA have
been cloned (Engelward et al., 1993; O'Connor and Laval,
1990; Samson et al., 1991; Chakravarti et al., 1991).
The enzyme's precise role in protecting cells from the
cytotoxic effects of alkylating agents is still controversial
(Klungland et al., 1992; Habraken and Laval, 1993;
Imperatori et al., 1994; Ibeanu et al., 1992; Matijasevic et
al., 1993). Klungland et al. (1992) reported that V79 hamster
lung fibroblasts and murine haematopoietic cells permanently
expressing the tag gene showed increased resistance to killing
by methylmethanesulphonate (MMS) and methylnitrosurea
(MNU). Habraken and Laval (1993) demonstrated that the
expression of the alkA or mammalian glycosylase in irsl cells
rendered them resistant to the toxic effects of both MMS and
ethylmethanesulphonate (EMS). However, Imperatori et al.
(1994) and Ibenau et al. (1992), who respectively transfected
the tag and the mammalian glycosylase gene in different cell
lines, could not find any increased resistance to the toxic
effects of alkylating agents in the stable transfectants, in spite
of the high level of glycosylase expression. It was suggested
that the level of the endogenous enzyme might account for
these differences. Further studies are needed to establish the
enzyme's role in the repair of the lesions induced by
alkylating agents and in determining tumour resistance to
the alkylating agents used in cancer chemotherapy. The lack
of data on the enzymatic activity of 3-meAde gly in human
tumour cells prompted us to conduct a study in which the
enzymatic activity was determined in a number of cancer cell
lines together with O6ATase level and sensitivity to alkylating
agents.
The alkylating agents selected were CC1065 and tallimus-
tine, known to alkylate N3 adenine in a DNA sequence
specific manner; N - methyl - NY - nitro -N - nitrosoguanidine
(MNNG) and dimethylsulphate (DMS) for their ability to
cause a broader alkylation pattern; and two cross-linking
agents, cis-diamminedichloroplatinum (cDDP) and melpha-
lan (L-PAM).
Materials and methods
Cell culture
The ovarian carcinoma cell lines IGROV, SW626, OV-
CAR3.S, SKOV-3, the human leukaemia cell lines CEM,
U937, K562 and Jurkat were maintained in RPMI-1640
(Gibco Europe, Glasgow, UK); human colon carcinoma cell
lines HT-29 and LoVo were maintained respectively in
Eagle's minimum essential medium (MEM) (Gibco) and F-
12 (Biological Industries) media. All cell lines were
supplemented with 10% fetal calf serum (Biological
Industries, Kibbutz Beth Haemek, Israel) and 2 mM
glutamine (Gibco) and grown at 37°C with 5% carbon
dioxide.
Northern blotting analysis
Total RNA from cell lines was separated from exponential
growing cells by the quanidium isothiocyanate/caesium
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chloride procedure (Chirgwin et al., 1979). After electrophor-
esis in a formaldehyde-agarose gel, RNA (10 Mg) was
transferred to nylon membranes and hybridised separately to
the random primed 32P-labelled probes for 16 h at 420C. The
1.2 kb 3-meAde gly probe was obtained by digesting the
puC9-MPG plasmid (generous gift from Professor B Kaina,
University of Mainz, Germany) with BamHI and the 0.8 kb
O6ATase probe was obtained by digesting the pKT100
plasmid (generous gift from Dr S Mitra, University of
Texas, TX, USA) with EcoRI. Membranes were washed in
2 x SSC at room temperature in 2 x SSC /1% sodium dodecyl
sulphate (SDS) at 650C and then autoradiographed.
RNA filters were rehybridised with murine oc-actin cDNA.
3-meAde gly assay
Cell pellets (50-70 x 106 cells ml-1) were resuspended in 20
mM Tris HCl, pH7.5 (40C) containing 1 mM DTT, 0.1 mM
EDTA, 0.1 mM phenylmethylsulphonyl fluoride (PMSF) and
crude cell extracts were obtained by sonication. Samples were
centrifuged to remove cellular debris and stored at - 80°C
until assay. Crude extracts (0.1-0.2 mg of protein) were
incubated in a constant volume of 140 ,l at 37°C for variable
intervals with aliquots of freshly N-[3H] MNU methylated
DNA containing (>) 1000 fmol of 3-[3H]methyladenine; the
reactions were stopped on ice at stated times. After addition
of the internal standard, DNA was precipitated with sodium
chloride-ethanol; supernatants were collected, dried, redis-
solved and [3H]methyladenine content analysed by radio-
chromatographic high-performance liquid chromatography
(HPLC); similar samples were incubated without protein
extracts to assess spontaneous depurination. The results were
calculated on the slope of time course of 3-meAde peak
radioactivity and were expressed as fmol repaired min-
mg-' DNA.
Total protein concentration was determined by the
Bradford dye-binding assay (Bio-Rad).
06ATase assay
O6ATase was assayed according to the method already
published (Catapano et al., 1987). Briefly, extracts of the
cell lines were obtained by sonication of the cellular pellets
resuspended in cold 50 mm Tris-HCl (pH 7.5), 1 mM DTT
and 0.01 mm EDTA. The supernatants were centrifuged
before assay. [3H]methylated calf thymus DNA was prepared
according to Wiestler et al. (1984). The [3H] methylated
substrate containing 06-meGua was incubated for 1 h at
37°C with variable amounts of crude cell extracts in 1.7 mM
DTT, 72 mM Tris-HCl, pH8 with or without cell extracts
(controls), then the DNA was precipitated by adding cold
1 N perchloric acid. The DNA pellet was hydrolysed by
heating at 70°C for 30 min in 0.1 N hydrochloric acid and
analysed by HPLC with the Hibar RP8 (4 x 250 mm) CB
reversed-phase prepacked column (Merck). Fractions of
eluted material were collected and assayed for radioactivity.
The sample DNA content was determined with the
diphenylamine assay. The results were expressed as fmol
u1g- DNA.
Growth inhibition assay
Briefly, cells were plated at a density ranging from 32 to
64 x 103 cells ml-' in 100 ,l of complete medium in 96-well
plates. After 48 h drugs were added at the concentrations
indicated. At the end of 2 h drug treatments, medium was
removed, cells were washed with warm phosphate-buffered
saline (PBS) and recovered in fresh medium. Ater 72 h
surviving fractions were stained with (3[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide) (MTT) for 4 h then the
staining solution was removed by aspiration and cells were
dissolved in 100 ,l of 1-propanol/0.025 N hydrochloric acid.
Absorbance at 570 nm was measured using a multiwell plate
reader (Titertek Multiscan MC340).
The IC50s were determined by interpolation of the dose-
response cytotoxic curves. The IC50 value for each drug is the
mean+ s.e. of at least three different experiments.
Drugs
DMS, MNNG (Sigma, St Louis, MO, USA.) and cDDP
(generous gift from Bristol Myers-Squibb, USA) were
dissolved in medium; L-PAM (kindly provided by Drug
Synthesis and Chemical Branch, Division of Cancer
Treatment, NCI, Bethesda, MD, USA) was dissolved in
0.3 N hydrochloric acid; stock solution of CC-1065 (1 mg
ml-') (kindly provided by Upjohn Co, Kalamazoo, MI,
USA) in dimethylacetamide (DMA) was diluted in medium
just before use; tallimustine (kindly provided by Pharmacia-
Farmitalia Carlo Erba, Milan, Italy) was dissolved in
dimethylsulphoxide (DMSO) and diluted to the desired
concentration in medium just before use.
Results
3-MeAde gly and O6ATase activities in different cell lines
A panel of ten cell lines was selected to measure 3-meAde gly
and O6ATase activities. As shown in Table I, the doubling
times were similar, except for the colon-rectum HT-29 and
LoVo cell lines, which showed longer times (46 and 44 h
respectively).
3-MeAde gly activity varied among the cell lines, being
lowest in the U937 line (0.11 fmol Mg` DNA min-') and
highest in LoVo cells (3.17 fmol yg-' DNA min-'). O6ATase
levels were variable, ranging from undetectable in U937 cells
to 24.5 fmol yg'- DNA in LoVo cells. Table I also shows the
mean+ s.e. of the DNA repair enzymatic activities of 3-
meAde gly and the O6ATase in the cell lines. Although
numbers were too small for a statistical comparison, the
Table I Doubling times, 3-meAde glycosylase and 06ATase activities in ten cell lines
Doubling time 3-meAde gly activity 06 ATase activity
Cell line (h) fmolpg--1 DNA min-' mean ±s.e. fmolylg-' DNA mean ±s.e.
Leukaemias
CEM 35± 3.6 0.80±0.079 17±0.5
JURKAT 29±1 1.41±0.10 07±02613±0.9 12±3.5
K562 28+1.1 0.77±0.09 0.77 0.26 5±0.3
U937 34± 0.6 0.11 ±0.006 ND
Ovarian carcinomals
IGROV 40±2 1.33±0.15 9±0.5
OVCAR3.S 32±0.9 0.24±0.019 3±0.4
SKOV-3 31±1 2.10±0.12 1.24±0.38 21±0.6 12±4
SW626 29±0.5 1.28±0.11 14±0.9
Colon-rectum carcinomals
HT-29 46±1.1 2.30±0.15 2.7410 0.43 1 0.9 21+3
LoVo 4±0.9 3.17n±o0.25 224±1
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levels of both activities were highest in colon - rectum cells,
intermediate in ovarian cells and lowest in cells of
haematopoietic origin.
There was a significant correlation (P<0.01) between 3-
meAde gly and O6ATase enzymatic activity (Figure 1).
Expression of mRNA codingfor 3-meAde gly and 06ATase
Figure 2 shows the Northern blot analysis of RNA extracted
from the different cell lines. 3-meAde gly transcript was
detected in all cells except OVCAR3.S, but the RNA
expression did not seem to be quantitatively correlated with
the enzymatic activity (Table I and Figure 2). For example,
the Jurkat cell line showed quite a high level of enzymatic
activity (1.41 fmol pg-' DNA min-1) but very low mRNA
expression (Figure 2, lane 3). The correlation between
O6ATase mRNA and its enzymatic activity was better, as
already reported (Fornace et al., 1990; Citron et al., 1993).
Cytotoxic effects ofdifferent alkylating agents on the cell lines
Table II shows theIC50 ofthe alkylating agents tested onthe ten
cell lines selected for this study. The drugs chosen were
tallimustine and CC-1065, two alkylating agents known to
bind totheminor groove ofDNAin asequence-specific manner
(Broggini etal., 1994); DMS and MNNG asmethylating agents
and cDDP and L-PAM as cross-linking agents. No correlation
was found between the levels of O6ATase and 3-meAde gly
activities and the IC50. For example, Jurkat cells that had high
levels ofboth enzymes, seemed tobethemostsensitive toalmost
allthedrugs, exceptL-PAM. Incontrast, OVCAR3.Scells,with
low levels of both 3-meAde gly and O6ATase, were more
resistant to tallimustine, CC-1065, DMS and MNNG than cells
with higher enzymatic levels.
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Figure 1 Relationship between the levels of 3-methyladenine-
DNA-glycosylase and 06-alkylguanine-DNA-alkyltransferase ac-
tivities. Each point represents the mean+s.e. of three determina-
tions.
Discussion
Ten human cancer cell lines were characterised for their 3-
meAde gly and O6ATase contents and their susceptibility to
different alkylating agents. The O6ATase levels varied in the
different cell lines, in the range of those reported in previous
studies (Fornace et al., 1990; Citron et al., 1993; Walker et
al., 1992). For 3-meAde gly, no comparison can be made, as
to our knowledge this is the first report describing the activity
of this DNA repair enzyme in human cancer cells. A 10-fold
difference in 3-meAde gly activity was observed in the cell
lines studied, with values ranging from 0.11 to 3.17 fmol pg'-
DNA min-' corresponding to 18-165 fmol mg-1 protein
min-'. These values seem to be much higher than those
reported for murine cancer cell lines, which ranged from 0.6
to 17 fmol mg-' protein min-' (Klungland et al., 1992;
Imperatori et al., 1994).
Similar interspecies differences have been observed for
other DNA repair enzymes: for example O6ATase in human
tissues is ten times higher than in mouse tissues (Gerson et
al., 1986). The cellular content of O6ATase correlated with
the levels of O6ATase mRNA, a finding that confirms
previous studies (Fornace et al., 1990; Citron et al., 1993;
Walker et al., 1992). However no correlation was found
between 3-meAde gly activity and 3-meAde gly mRNA
(Table I, Figure 2). There are several potential explanations
of these differences. Inactive 3-meAde gly molecules may be
synthesised in the non-functional state, or functional protein
might be inactivated. On the other hand the protein turnover
could be different in the different cell lines, resulting in
differences in the enzymatic activities. Interestingly, the
simultaneous expression of alternatively spliced 3-meAde
gly transcripts in human tissues and cells by reverse
transcriptase-polymerase chain reaction (RT-PCR) of total
CEM
JURKAT
K562
U937
IGROV
OVCAR3.S
SKOV3
SW626
HT29
LoVo
Actin 06ATase 3meAde gly
Figure 2 Northern blot analysis of 3-methyladenine-DNA-
glycosylase and 06-alkylguanine-DNA-alkyltransferase and a-
actin expression in ten cell lines.
Table H IC50 of various agents on ten human cell lines
Tallimustine CC-1065 DMS MNNG cDDP L-PAM
Cell line (UM) (UM) (UM) (UM) (UM) (UM)
CEMM 0.06+0.005 4.3+0.8 364+ 19 60+5 9+2 1+0.2
JURKAT 2.3± 1.3 0.4+0.16 216±56 26+4 8±2 6+1
K562 24+7 11±1 350+66 40+8 68+5 111±20
U937 9+3 3+0.6 310+44 9+2 23+3 10±0.3
IGROV 15+ 1 6+0.8 976+75 131+20 28+2 151±33
OVCAR3.S 83± 16 4±3 835+26 130+51 35+5 65±6
SKOV-3 8+3 6±1 866+ 105 66+7 83+ 12 102+3
SW626 9.5+1 8±1 886+ 54 67+ 23 62± 5 128 ±26
HT-29 19± 11 25 ± 8 1503 + 159 370+ 31 253+ 13 184±26
LOVO >136 6+0.6 960+5 78+5 99±14 88+63-MeAde Gly, 06ATase and sensitivity to alkylating agents
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RNA has been demonstrated recently (Pendlebury et al.,
1994). The functional role, if any, of these two isoforms has
yet to be established. They might display different substrate
specificity, even if there are no data yet to confirm this
hypothesis. The probe we used for the 3-meAde gly mRNA
detection is homologous for both these isoforms, so that the
discrepancy between the mRNA expression and the
enzymatic activity, based on the ability to remove labelled-
3-meAde from DNA, could also be explained by the different
substrate specificity of the two isoforms.
Interestingly, we found a significant correlation (P<0.01)
between the levels of enzymatic activity. To our knowledge
no data have been published so far on the expression and
activity of these two DNA repair enzymes in the same human
cell lines. In E. Coli, both enzymes exist as constitutive
(respectively the tag and otg gene products) (Sakumi et al.,
1986; Bjelland and Seeberg, 1987; Pegg and Byers, 1992) or
inducible forms (respectively the AlkA and ada gene
products) (Nakabeppu et al., 1984; Karran et al., 1982;
Evensen and Seeberg, 1982). This induction, which is termed
the adaptive response, is an efficient system that enables E.
Coli to respond to damage by alkylating agents. In
Saccaromyces cerevisiae the alkylation damage is repaired
by a methyltransferase (encoded by MTGI) and 3-meAde gly
(encoded by MAG) that releases O6meGua, 3meAde and
7meAde from alkylated DNA (Chen et al., 1990; Xiao and
Samson, 1992). MAG but not MTGJ is inducible by DNA
damage (Chen and Samson, 1991; Xiao et al., 1991). A
decamer consensus sequence has been recently identified in
the promoters of the MAG, MGTI and several other genes
involved in the DNA repair and metabolism (Xiao et al.,
1993), suggesting a common mechanism of regulation. In
mammalian cells induction of alkyltransferase activity has
been shown in some cases, but the changes are much more
modest than the ones seen in E. Coli, up to 10-fold. Induction
of O6ATase has been reported in human cancer cells after
challenge with alkylating agents, but this finding has not
always been confirmed (Pegg, 1990; Laval, 1990, 1991). The
mechanisms underlying these increases have not been studied
in detail, but they are probably at the level of transcription
(Laval, 1991).
Our finding that the contents of these two DNA repair
proteins, which are involved in the repair of alkylated DNA,
are correlated suggests a common mechanism of regulation,
and studies are currently underway in our laboratory to
clarify this.
We found no correlation between the level of 3-meAde gly
and the sensitivity to different alkylating agents, methylating
agents or other alkylators with different structure and
different interactions with DNA. In the case of tallimustine
and CC-1065, two minor groove binders known to alkylate
N3 adenine in a sequence-specific manner (Broggini et al.,
1994), the explanation could be that the kind of adduct
formed on N3 adenine is bulky and might not be recognised
and cleaved by the enzyme. For the cross-linking agents L-
PAM and cDDP too, the cytotoxic lesions appear to be the
cross-links between two adjacent guanines or guanines
located on opposite strands, so the alkylation of N3 adenine
might be relatively unimportant for their cytotoxicity. In fact
it has been shown that the nucleotide excision repair plays an
important role in the repair of the lesions caused by cDDP
and L-PAM treatment (Lee et al., 1993; Larminat and Bohr,
1994).
For methylating agents (DMS and MNNG) the lack of
correlation between the levels of the DNA repair protein and
the sensitivity confirmed previous findings (Imperatori et al.,
1994) on murine cells expressing the E. Coli tag or human
MPG gene, which did not become resistant to the toxic
effects of methylating agents. As already proposed, the
endogenous levels of 3-meAde gly might be the crucial
factor governing the sensitivity to methylating treatment. In
the ten lines selected for this study, the 3-meAde gly contents
were relatively high, possibly sufficient per se to repair the 3-
meAde adduct caused by treatment with alkylating agents. In
fact, resistance to methylating treatment has been reported in
cell lines transfected with the tag gene, with an increase in the
level of repair activity from 0.6 to 4.3 fmol mg-' protein
min-1 (O'Connor and Laval, 1990).
The other major factor for resistance to methylating
agents is the cellular content of O6ATase. However, no
correlation between the transferase activity and cellular
sensitivity to different alkylating agents, particularly with
MNNG and DMS, which are known to cause the highest
proportion of O6meGua was found. It has already been
shown that the sensitivity to MNNG is not necessarily
associated with O6ATase level (Lefebvre and Laval, 1993).
Recently a defective mismatch repair has also been implicated
in resistance and tolerance to some alkylating agents (such as
MNU and MNNG). In this case 06-meGua persists in
tolerant cells but is no longer lethal. The current underlying
hypothesis is that methylation tolerance arises through the
loss of a mismatch repair system that is defective in many
tolerant cells (Karran and Bignami, 1994).
In conclusion, the present findings suggest that the two
repair enzymes, 3meAde gly and O6ATase, are not necessarily
vital to the sensitivity to various alkylating agents. It is likely
that after DNA damage a cascade of events occurs, resulting
in a certain degree of survival. For example, two cell lines
may have the same level of DNA damage and the same rate
of adduct removal but the activation of different pathways
for cell survival, for example activation of different proteins
involved in cell growth and survival (e.g. p53), so that no
single factor is likely to be responsible for the sensitivity or
resistance to a certain drug.
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